Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Multicomponent Reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109053603A enables aqueous synthesis of triazoles. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN110483387B reveals a novel one-pot synthesis for 2,N,4,5,6-pentasubstituted nicotinamide derivatives, offering high yields and simplified purification for pharmaceutical intermediate manufacturing.
Patent CN110317221B reveals a novel palladium-catalyzed route to polysubstituted alkynamidines using simple alkynyl bromides and isonitriles, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Pd-catalyzed multicomponent method for indolinone-imidazole derivatives. Safe, scalable, CO-free process for high-purity pharmaceutical intermediates.
Novel MOF-Cu catalyzed Ugi reaction for isoindolinone derivatives. Efficient, scalable, and cost-effective synthesis for pharma and agrochemical applications.
Patent CN115353511A details a safe Pd-catalyzed route avoiding toxic CO gas, offering reliable pharmaceutical intermediate suppliers cost-effective scalable manufacturing solutions.
Patent CN113234015B discloses a high-yield one-pot synthesis of 3-acyl dihydroquinolines. This route offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN111718301B reveals a one-step synthesis for quinazolinone derivatives using isatoic anhydride. Discover cost-effective manufacturing and scalable supply chain solutions.
Novel Pd-catalyzed multicomponent method for indolinone-imidazole derivatives. Safe, scalable, CO-free process for high-purity pharmaceutical intermediates.
Patent CN112480015A reveals a novel one-pot method for synthesizing 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction and safety improvements for API manufacturing.
Patent CN121426725A reveals novel palladium-catalyzed route for sulfone-carbonyl units. Delivers supply chain stability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110183378A reveals a novel copper-catalyzed route for high-purity nicotinamide derivatives, offering significant supply chain and cost advantages.
Patent CN114573631A details a novel three-component reaction for paclitaxel side chains. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel one-step copper-catalyzed method for 2-amino-5-thioindole derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112441981B details a novel one-step synthesis for imidazoles, offering high regioselectivity and supply chain efficiency for pharma intermediates.
Discover a novel metal-free synthesis for polysubstituted pyrroles using alpha-hydroxy ketones. Enhance supply chain reliability and reduce manufacturing costs.
Novel one-step acid-catalyzed method for quinazolinones using isatoic anhydride. High purity, scalable, cost-effective pharmaceutical intermediates manufacturing.
Patent CN116640146B enables efficient synthesis of trifluoromethyl chromonoquinoline intermediates through palladium-catalyzed multicomponent reactions with simplified processing and scalable manufacturing advantages.
Novel palladium-catalyzed method enables efficient synthesis of trifluoromethyl chromone quinoline intermediates with simplified purification and enhanced supply chain reliability for pharmaceutical manufacturing.
Palladium-catalyzed synthesis enables high-purity pyrrolofuran intermediates with cost reduction in pharmaceutical manufacturing.